BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

287 related articles for article (PubMed ID: 30597183)

  • 1. Dengue drug discovery: Progress, challenges and outlook.
    Lim SP
    Antiviral Res; 2019 Mar; 163():156-178. PubMed ID: 30597183
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting dengue virus NS4B protein for drug discovery.
    Xie X; Zou J; Wang QY; Shi PY
    Antiviral Res; 2015 Jun; 118():39-45. PubMed ID: 25796970
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ten years of dengue drug discovery: progress and prospects.
    Lim SP; Wang QY; Noble CG; Chen YL; Dong H; Zou B; Yokokawa F; Nilar S; Smith P; Beer D; Lescar J; Shi PY
    Antiviral Res; 2013 Nov; 100(2):500-19. PubMed ID: 24076358
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Strategies for development of Dengue virus inhibitors.
    Noble CG; Chen YL; Dong H; Gu F; Lim SP; Schul W; Wang QY; Shi PY
    Antiviral Res; 2010 Mar; 85(3):450-62. PubMed ID: 20060421
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of a dengue NS4B inhibitor originating from an HCV small molecule library.
    Hernandez-Morales I; Geluykens P; Clynhens M; Strijbos R; Goethals O; Megens S; Verheyen N; Last S; McGowan D; Coesemans E; De Boeck B; Stoops B; Devogelaere B; Pauwels F; Vandyck K; Berke JM; Raboisson P; Simmen K; Lory P; Van Loock M
    Antiviral Res; 2017 Nov; 147():149-158. PubMed ID: 29037976
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The search for nucleoside/nucleotide analog inhibitors of dengue virus.
    Chen YL; Yokokawa F; Shi PY
    Antiviral Res; 2015 Oct; 122():12-9. PubMed ID: 26241002
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dengue Virus Evolution under a Host-Targeted Antiviral.
    Plummer E; Buck MD; Sanchez M; Greenbaum JA; Turner J; Grewal R; Klose B; Sampath A; Warfield KL; Peters B; Ramstedt U; Shresta S
    J Virol; 2015 May; 89(10):5592-601. PubMed ID: 25762732
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular Mechanisms of Antiviral Agents against Dengue Virus.
    Lee MF; Wu YS; Poh CL
    Viruses; 2023 Mar; 15(3):. PubMed ID: 36992414
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dengue Virus Reporter Replicon is a Valuable Tool for Antiviral Drug Discovery and Analysis of Virus Replication Mechanisms.
    Kato F; Hishiki T
    Viruses; 2016 May; 8(5):. PubMed ID: 27164125
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structure-Based Design of Antivirals against Envelope Glycoprotein of Dengue Virus.
    Anasir MI; Ramanathan B; Poh CL
    Viruses; 2020 Mar; 12(4):. PubMed ID: 32225021
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preclinical Antiviral Testing for Dengue Virus Infection in Mouse Models and Its Association with Clinical Studies.
    Watanabe S; Low JG; Vasudevan SG
    ACS Infect Dis; 2018 Jul; 4(7):1048-1057. PubMed ID: 29756760
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of Broad-Spectrum Dengue/Zika Virus Replication Inhibitors by Functionalization of Quinoline and 2,6-Diaminopurine Scaffolds.
    Kaptein SJF; Vincetti P; Crespan E; Rivera JIA; Costantino G; Maga G; Neyts J; Radi M
    ChemMedChem; 2018 Jul; 13(14):1371-1376. PubMed ID: 29740962
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discovery of Immunologically Inspired Small Molecules That Target the Viral Envelope Protein.
    Lian W; Jang J; Potisopon S; Li PC; Rahmeh A; Wang J; Kwiatkowski NP; Gray NS; Yang PL
    ACS Infect Dis; 2018 Sep; 4(9):1395-1406. PubMed ID: 30027735
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recent update on anti-dengue drug discovery.
    Dighe SN; Ekwudu O; Dua K; Chellappan DK; Katavic PL; Collet TA
    Eur J Med Chem; 2019 Aug; 176():431-455. PubMed ID: 31128447
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dengue Antiviral Development: A Continuing Journey.
    Low JG; Gatsinga R; Vasudevan SG; Sampath A
    Adv Exp Med Biol; 2018; 1062():319-332. PubMed ID: 29845542
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel flavivirus entry inhibitor, BP34610, discovered through high-throughput screening with dengue reporter viruses.
    Yang CC; Hu HS; Lin HM; Wu PS; Wu RH; Tian JN; Wu SH; Tsou LK; Song JS; Chen HW; Chern JH; Chen CT; Yueh A
    Antiviral Res; 2019 Dec; 172():104636. PubMed ID: 31654671
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Development of Peptide-based Antimicrobial Agents against Dengue Virus.
    Huang YW; Lee CT; Wang TC; Kao YC; Yang CH; Lin YM; Huang KS
    Curr Protein Pept Sci; 2018; 19(10):998-1010. PubMed ID: 29852867
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Small molecule drug discovery for Dengue and West Nile viruses: applying experience from hepatitis C virus.
    Parkinson T; Pryde DC
    Future Med Chem; 2010 Jul; 2(7):1181-203. PubMed ID: 21426163
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dengue Virus and Its Inhibitors: A Brief Review.
    Tian YS; Zhou Y; Takagi T; Kameoka M; Kawashita N
    Chem Pharm Bull (Tokyo); 2018; 66(3):191-206. PubMed ID: 29491253
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peptide inhibitors against dengue virus infection.
    Panya A; Bangphoomi K; Choowongkomon K; Yenchitsomanus PT
    Chem Biol Drug Des; 2014 Aug; 84(2):148-57. PubMed ID: 24612829
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.